simvastatin has been researched along with Delirium of Mixed Origin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, A; Heslegrave, A; McAuley, DF; Page, VJ; Sanders, RD; Watne, LO; Zetterberg, H | 1 |
| Corradi, JP; Dicks, R; Duan, Y; Grady, J; Mather, JF; Noyes, A; Waszynski, C | 1 |
| Casarin, A; Ely, EW; McAuley, DF; McDowell, C; Murphy, L; Page, VJ; Zhao, XB | 1 |
| Agus, A; McAuley, DF; Page, VJ; Phair, G | 1 |
| Agus, A; Alce, TM; Casarin, A; Ely, EW; Jackson, JC; McAuley, DF; McDowell, C; Murphy, L; Page, VJ; Zhao, X | 1 |
2 trial(s) available for simvastatin and Delirium of Mixed Origin
| Article | Year |
|---|---|
Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation (MoDUS): a randomised, double-blind, placebo-controlled trial.
Topics: Aged; Anti-Inflammatory Agents; Coma; Critical Care; Critical Illness; Delirium; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Simvastatin; Time Factors; Treatment Outcome | 2017 |
Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Anti-Inflammatory Agents; Biomarkers; Butyrylcholinesterase; Clinical Protocols; Cognition; Critical Illness; Delirium; Drug Administration Routes; England; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Intensive Care Units; Length of Stay; Neuroprotective Agents; Research Design; Respiration, Artificial; Risk Factors; Simvastatin; Time Factors; Treatment Outcome | 2015 |
3 other study(ies) available for simvastatin and Delirium of Mixed Origin
| Article | Year |
|---|---|
Plasma neurofilament light chain protein as a predictor of days in delirium and deep sedation, mortality and length of stay in critically ill patients.
Topics: Adult; Biomarkers; Critical Illness; Deep Sedation; Delirium; Humans; Intermediate Filaments; Length of Stay; Neurofilament Proteins; Randomized Controlled Trials as Topic; Simvastatin | 2022 |
Statin and Its Association With Delirium in the Medical ICU.
Topics: Aged; Atorvastatin; Delirium; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive Care Units; Male; Middle Aged; Odds Ratio; Pravastatin; Propensity Score; Reproducibility of Results; Retrospective Studies; Simvastatin | 2017 |
Simvastatin for the prevention and treatment of delirium in critically ill, mechanically ventilated patients (MoDUS): a cost-effectiveness analysis.
Topics: Cost-Benefit Analysis; Critical Illness; Delirium; Humans; Intensive Care Units; Respiration, Artificial; Simvastatin | 2018 |